HealthTree News

HealthTree News is a place to learn all about your disease in easy-to-understand language. The site features news articles, patient stories, basics articles, and clinical trial updates with new content every week.

Headlines All Categories Treatment Advances Navigating Your Health Core Education Patient Stories HealthTree Research Conferences Clinical Trials HealthTree Programs HealthTree Press

Recent Articles

A New Medication For T-Cell Lymphoma On The Skin

April 18, 2025

Learn about denileukin diftilox, a new FDA-approved treatment for relapsed cutaneous T-cell lymphoma (CTCL), and how it may help patients.

Golcadomide for Aggressive Lymphoma

April 18, 2025

Learn more about updates of golcadomide in combination with other treatments for high-risk aggressive lymphoma.

Navigating “Not Looking Sick” Living with Chronic Blood Cancer

April 17, 2025

Living with chronic blood cancer but feel unseen or misunderstood? You're not alone. Find support, tools, and validation here.

How Blood Cancer Patients Are Finding Purpose, Growth, and Meaning After Diagnosis

April 16, 2025

HealthTree survey results show that patients can flourish and find deeper meaning in their lives following a cancer diagnosis

Targeting ROR1 in Blood Cancers

April 16, 2025

Understanding how ROR1-targeted therapies work—and whether they apply to your specific blood cancer type—can help you make more informed treatment decisions.

Navigating Financial Uncertainty: Proactive Tips for Blood Cancer Patients and Their Families

April 14, 2025

Learn how recent healthcare policy changes can affect you. Tips on Medicaid changes, Social Security delays, and drug shortages. Join our financial webinars.

HealthTree Foundation CEO Jenny Ahlstrom Honored as 2025 Remarkable Women Honoree by ABC4 Utah

April 11, 2025

HealthTree Foundation's CEO Jenny Ahlstrom recognized by ABC4 Utah for her work in cancer patient care and research through technology.

Odronextamab Shows Early Success for High-Risk Follicular Lymphoma

April 02, 2025

Initial OLYMPIA-1 results show odronextamab may offer a chemo-free first treatment option for high-risk follicular lymphoma patients.

Does Fructose Support Cancer Cells?

April 02, 2025

Discover how fructose affects cancer cells' growth based on recent animal studies and learn the potential implications for human health.

Loncastuximab for High-Risk R/R Follicular Lymphoma

March 28, 2025

In this article, discover how loncastuximab with rituximab shows promise for relapsed/refractory high-risk follicular lymphoma in a phase 2 clinical trial.

HealthTree News

Recent Articles